China Renji Medical Group Limited (SEHK:648) sold 20% stake in Wintin International Limited for HKD 26 million on December 1, 2014. China Renji Medical Group Limited will dispose 20 shares in Wintin International Limited representing 20% stake in Wintin International Limited, consideration will be paid HKD 6 million immidiately, HKD 5 million on February 28, 2015 and remaining within 10 business days following the issue of the confirmation letter prepared by the auditors in respect of the audited consolidated net asset value of Wintin International Limited. China Renji Medical Group Limited shall have the right to appoint three Directors and remaining shareholders of Wintin International Limited will be entitled to appoint one Director. Wintin International Limited reported net loss of HKD 120.84 million, revenues of HKD 139.63 million and revenues of 112.98 million in year ended December 31, 2013. The proceeds from the transaction shall be used for purposes of working capital for the ongoing business development of China Renji and for appropriate acquisition opportunities.

China Renji Medical Group Limited (SEHK:648) completed the sale of 20% stake in Wintin International Limited on December 1, 2014.